Literature DB >> 3468194

Modulation of the pattern of development of experimental disseminated leishmaniasis by Corynebacterium parvum.

J O Hill.   

Abstract

BALB/c mice are extremely susceptible to Leishmania major. In this mouse strain, the parasite multiplies progressively and rapidly disseminates to distant visceral and cutaneous sites. The present studies show, however, that if BALB/c mice are infected with the L major as an admixture with formalin-killed Corynebacterium parvum, they rapidly acquire the capacity to restrain the multiplication of the parasite at the site of inoculation, and prevent its dissemination to distant visceral sites. Moreover, admixture-treated mice subsequently develop systemic resistance to reinfection. Although the ability of C parvum to activate nonspecific microbicidal mechanisms of macrophages may be involved, the requirement that the adjuvant be given with the parasite inoculum is interpreted to suggest that C parvum facilitates the development of a protective immune response to the parasite.

Entities:  

Mesh:

Year:  1987        PMID: 3468194     DOI: 10.1002/jlb.41.2.165

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  5 in total

1.  Membrane glycoprotein M-2 protects against Leishmania amazonensis infection.

Authors:  J Champsi; D McMahon-Pratt
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

2.  Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania.

Authors:  J O Hill; M Awwad; R J North
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

3.  Propionibacterium acnes Enhances the Immunogenicity of HIVBr18 Human Immunodeficiency Virus-1 Vaccine.

Authors:  Daniela Teixeira; Mayari Eika Ishimura; Juliana de Souza Apostólico; Jacqueline Miyuki Viel; Victor Cabelho Passarelli; Edecio Cunha-Neto; Daniela Santoro Rosa; Ieda Maria Longo-Maugéri
Journal:  Front Immunol       Date:  2018-02-07       Impact factor: 7.561

4.  Use of a recombinant cysteine proteinase from Leishmania (Leishmania) infantum chagasi for the Immunotherapy of canine visceral Leishmaniasis.

Authors:  Josie Haydée Lima Ferreira; Lucilene Dos Santos Silva; Ieda Maria Longo-Maugéri; Simone Katz; Clara Lúcia Barbiéri
Journal:  PLoS Negl Trop Dis       Date:  2014-03-13

5.  Killed Propionibacterium acnes enhances immunogenicity and tumor growth control of a dendritic-tumor cell hybrid vaccine in a murine melanoma model.

Authors:  Mayari E Ishimura; Daniela Teixeira; Gabriela da P Silveira; Mônica Gambero; Gabriel A C Gama; Bruna S O Pimenta; Elaine G Rodrigues; Ieda M Longo-Maugéri
Journal:  PLoS One       Date:  2018-10-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.